Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Celgene's (CELG) board authorizes the repurchase of an additional $2.5B of the pharmaceutical...

  • Wednesday, June 13, 2012, 8:17 AM ET
    Celgene's (CELG) board authorizes the repurchase of an additional $2.5B of the pharmaceutical company's shares, which it will carry out in the open market or in privately negotiated transactions from time to time. (PR)
Track new comments on this story

This news story has 1 comment:

  •  
    They would do allot more for their shares if they began a dividend.
    13 Jun 2012, 02:27 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)
Latest Articles
More Latest Articles »